Vanda Pharmaceuticals Other Equity Adjustments (Quarterly) Insights

Vanda Pharmaceuticals, Inc. (VNDA)

8.26 +2.50 (+43.40%) USD | NASDAQ | Feb 23, 15:14

View Other Equity Adjustments (Quarterly) for VNDA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Equity Adjustments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Equity Adjustments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Equity Adjustments (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Axsome Therapeutics, Inc.	--
AnaptysBio, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	--
Protagenic Therapeutics, Inc.	Upgrade